1. Home >
  2. Medicine Info >
  3. Nebiring 2.5 MG Tablet

Nebiring 2.5 MG Tablet

Manufactured by: Orchid Chemicals & Pharmaceuticals Ltd.
Composition: Nebivolol
Prescription Required: Yes
More
    Contents

Description

Nebiring 2.5 MG Tablet is used for the lowering of high blood pressure and relieving chest pain caused due to reduced blood flow to the heart. It is also used for treating other complications associated with heart and blood vessels.

Side effects

Major & minor side effects for Nebiring 2.5 MG Tablet

  • Headache
  • Dizzinesssevererare
  • Unusual tiredness and weakness
  • Diarrhea
  • Increase in body fat and cholesterol
  • Sleeplessness
  • Swelling of face, lips, eyelids, tongue, hands and feet severerare
  • Chest pain and discomfortsevere
  • Decreased blood pressure
  • Difficulty in breathingsevererare
  • Weight gain
  • Burning, numbness, tingling in the arms and feet
  • Allergic Skin Reactionsevererare
SEVERE
Contact your doctor immediately if any of these symptoms are experienced on a regular basis.
RARE
Observed in a small fraction of population.
This is not an exhaustive list of side effects. Please inform your doctor if you experience any adverse reaction to the medication.

Highlights

Commonly asked questions for Nebiring 2.5 MG Tablet

Onset of action

The effect of this medicine can be observed within 1-2 hours of administration.

Duration of effect

The effect of this medicine lasts for an average duration of 10-12 hours.

Safe with alcohol?

moderate
Use of alcohol should be avoided while taking Nebiring 2.5 MG Tablet especially when you start taking the medicine or change the dosage. Symptoms like headache, dizziness, change in pulse or heart rate should be reported to the doctor.

Is it habit forming?

No habit forming tendencies were reported.

Usage in pregnancy?

This medicine is not recommended for use during pregnancy unless absolutely necessary. Consult your doctor about the potential benefits and risks before deciding to take this medicine. Even if the medicine is used, the dose should be as low as possible and should be discontinued at least 2-3 days before delivery.

Usage while breast-feeding?

This medicine is not recommended for use by breastfeeding women unless absolutely necessary. The infant should be monitored for adverse effects like changes in pulse rate, respiratory changes, and low blood sugar levels. Consult your doctor before taking this medicine.

Substitutes

List of substitutes for Nebiring 2.5 MG Tablet

Below is the list of medicines, which have the same composition, strength and form as Nebiring 2.5 MG Tablet, and hence can be used as its substitute.
Nebest 2.5 MG Tablet
Usv Ltd.
Nebilong 2.5 MG Tablet
Micro Labs Ltd.
Nebitime 2.5 MG Tablet
Mankind Pharmaceuticals Ltd.
Niavas 2.5 MG Tablet
Ranbaxy Laboratories Ltd.
Nodon 2.5 MG Tablet
Cadila Pharmaceuticals Ltd.

What is it prescribed for?

Uses of Nebiring 2.5 MG Tablet

  • Hypertension

    Nebiring 2.5 MG Tablet is used for lowering high blood pressure in patients suffering from hypertension.

  • Heart Failure

    Nebiring 2.5 MG Tablet is also used to relieve the symptoms of heart failure by improving the blood flow to the heart.

Find a doctor near you

Looking for a doctor?

Book an appointment with the top doctors near you.

When not to use?

Contraindications of Nebiring 2.5 MG Tablet

  • Allergy

    Nebiring 2.5 MG Tablet is not recommended for people who have a known history of allergy to this medication or any other medicines belonging to the group Beta Blockers. (Eg: Atenolol, Labetalol etc).

  • Liver disease

    Nebiring 2.5 MG Tablet is not recommended for people having a severe liver impairment.

  • Circulatory disorders

    Nebiring 2.5 MG Tablet is not recommended for people suffering from blood circulation disorders or cardiogenic shock.

  • Heart Failure

    Nebiring 2.5 MG Tablet is not recommended for use in people suffering from severe heart failure or people receiving emergency attention.

  • Heart diseases

    Nebiring 2.5 MG Tablet is not recommended for people who have serious heart problems like heart block and Sick Sinus Syndrome, especially if no pacemaker has been implanted to correct the defect.

  • Bronchial asthma

    Nebiring 2.5 MG Tablet is not recommended for use in people having a history of bronchial asthma and bronchospasm or any other condition in which the airway is obstructed.

  • Heart rhythm disorders

    Nebiring 2.5 MG Tablet is not recommended for use in people having heart rhythm disorders like Bradycardia.

Dosage

  • Missed Dose

    Take the missed dose as soon as you remember. However, the missed dose can be skipped if it is almost time for the next scheduled dose.

  • Overdose

    An overdose of this medication can cause some serious effects on the heart, blood vessels, and nerve conduction. Report the incidence as soon as possible so that medical intervention can begin. Supportive measures like Gastric lavage and symptomatic treatment might be required based on severity.

Interactions

All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.

Interaction with Alcoholmoderate

  • Description

    - Using alcohol while taking Nebiring 2.5 MG Tablet may cause an additional lowering of the blood pressure.

  • Instructions

    - Use of alcohol should be avoided while taking Nebiring 2.5 MG Tablet especially when you start taking the medicine or change the dosage. Symptoms like headache, dizziness, change in pulse or heart rate should be reported to the doctor.

Interaction with Medicine

Disease interactions

  • Asthma

    severe
    Nebiring 2.5 MG Tablet should not be used in patients suffering from bronchial asthma or Chronic Obstructive Pulmonary Disease. Report the incidence of Asthma to your doctor so that Nebiring 2.5 MG Tablet can be substituted with another medication.

  • Heart Block

    severe
    Nebiring 2.5 MG Tablet should not be used in patients having a heart block greater than first degree. However, it can be used in this case if a pacemaker is present to correct the disorder.

  • Diabetes

    severe
    Nebiring 2.5 MG Tablet should be administered with caution in patients suffering from diabetes or a condition where blood sugar level is likely to get low. You should consult a doctor if any symptom indicating a lowered blood sugar level is suspected while using this medicine.

  • Liver Disease

    moderate
    Nebiring 2.5 MG Tablet should be administered with caution in patients having a liver disease. Suitable dose adjustment and safety monitoring are advised in cases where the impairment is severe.

  • Glaucoma

    moderate
    Nebiring 2.5 MG Tablet should be administered with caution in a patient suffering from Glaucoma. A change in the dose of current Glaucoma medicine may be required. In some cases, your doctor may advise the use of another medicine in place of a beta blocker.

  • High cholesterol and fat

    moderate
    Nebiring 2.5 MG Tablet should be administered with caution in a patients having high levels of cholesterol and fat in their body. Suitable dose adjustment and safety monitoring may be required in such cases.

  • Hyperthyroidism

    moderate
    Nebiring 2.5 MG Tablet should be used with caution in patients having high thyroid hormone levels. Special caution should be taken while withdrawing this medicine. The dosing and effects of the medicine should be closely monitored.

  • Myasthenia Gravis

    moderate
    Nebiring 2.5 MG Tablet should be used with caution in patients suffering from this condition characterized by severe muscle weakness.

  • Pheochromocytoma

    moderate
    Nebiring 2.5 MG Tablet should be used with caution in patients suffering from this condition. The treatment should be suitably combined with an alpha-blocker with appropriate dosing and clinical monitoring.

Food interactions

  • Information not available.

Lab interactions

  • Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.

General Instructions

Take Nebiring 2.5 MG Tablet as instructed by the doctor. The dosage is likely to change based on your response to the medicine. It is advised to take this medicine at the same time of the day. The blood pressure should be monitored at regular intervals to ensure that the response at given dose is appropriate. Do not start or discontinue the usage of any other medication without consulting your doctor.

Warnings

Warnings for special population

  • Pregnancy

    - This medicine is not recommended for use during pregnancy unless absolutely necessary. Consult your doctor about the potential benefits and risks before deciding to take this medicine. Even if the medicine is used, the dose should be as low as possible and should be discontinued at least 2-3 days before delivery.

  • Breast-feeding

    - This medicine is not recommended for use by breastfeeding women unless absolutely necessary. The infant should be monitored for adverse effects like changes in pulse rate, respiratory changes, and low blood sugar levels. Consult your doctor before taking this medicine.

General warnings

  • Anesthetics

    - Nebiring 2.5 MG Tablet should be used with caution while a patient is given anesthesia as the risk of adverse effects on the heart and blood circulation is high.

  • Heart failure

    - Nebiring 2.5 MG Tablet can cause heart failure and reduced flow of blood especially in people having a heart disease. Suitable dose adjustment and safety monitoring might be required based on the severity of the disease.

  • Ischemic heart disease

    - Nebiring 2.5 MG Tablet should not be discontinued abruptly in patients with Ischemic heart disease. The dosage should be gradually reduced over a period of 1 to 2 weeks

  • Major surgery

    - Nebiring 2.5 MG Tablet should be given with caution to patients who are going to undergo a major surgery. The dose should be very carefully monitored in such cases both before and after the surgical procedure.

  • Pheochromocytoma

    - Nebiring 2.5 MG Tablet should be administered with caution in patients having this condition which results in an excess of substance that controls heart beat, blood pressure etc. Suitable medicine combinations is to be given in order to counter the effects.

  • Bronchospastic disease

    - Nebiring 2.5 MG Tablet should be administered with caution in patients having a disease of the lung or the airways leading to the lung. It can be Pneumonia, Asthma or Chronic Obstructive Pulmonary Disease. Suitable dose adjustment and safety monitoring are necessary in such cases.

  • Diabetes and hypoglycemia

    - Nebiring 2.5 MG Tablet should be administered with caution in patients having elevated blood sugar levels. Some adverse effects may not be evident in these cases and hence doctor's intervention is a must before taking this medicine.

  • Thyrotoxicosis

    - Nebiring 2.5 MG Tablet should be administered with caution in patients having elevated thyroid hormone level. Some adverse effects may not be evident in these cases and hence doctor's intervention is a must before taking this medicine.

  • Peripheral vascular disease

    - Nebiring 2.5 MG Tablet should be administered with caution in patients having narrowed blood vessels in the body due to any underlying reason. Dose adjustment and safety monitoring might be required in such cases.

  • Other medicine

    - Nebiring 2.5 MG Tablet can react with medicines that you might use. Report the use of all medicines including supplements and herbs to the doctor.

  • Sports

    - It is advised to not indulge in certain sports while Nebiring 2.5 MG Tablet is consumed. Archery, racing, shooting and other high-risk sports should be avoided. Sportspersons should refer to the list of medicine published by World Anti-Doping Agency which is not to be taken while participating in specific sports events.

Other details

  • To be taken with food
  • To be taken as instructed by doctor
  • May cause sleepiness

How it works

This medicine works by relaxing the blood vessels and slowing the heart beat. This results in an improved blood flow to the heart and the blood pressure is lowered.

Legal Status

Approved
Approved
Approved
Approved

Classification

Category
Cardioselective beta blockers
Schedule
Schedule H

References

Chat with a doctor

Get reply within 5 mins

How will this medicine affect me?

Chat with verified doctors starting @ ₹99

Did you find this helpful?

Your feedback will help us improve the product

Thanks for your response
What can we improve?
Thanks for your response
Information on this page was last updated on 16 Nov 2017

Report an error

Oops! Seems like there is an error in your form. Make sure -
  1. Your email ID is correct.
  2. Your response is not blank.
  3. Your internet is working.
Thank you!
Your response is valuable to us.

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.